Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 1631 entries
View as:

Sun Protection Factor Assay (SPF Assay 203/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02930798 Org: User:
Start: 10/18/16 End: 10/19/16 Due: 10/19/17

To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup

Phase: N/A Priority: Normal
NCT ID: NCT02593747 Org: User:
Start: 12/31/15 End: 03/31/16 Due: 03/31/17

Real-world Dosing Patterns of Rivaroxaban in the United States

Phase: N/A Priority: Normal
NCT ID: NCT03242278 Org: User:
Start: 02/12/16 End: 03/01/16 Due: 03/01/17

Use of Direct Oral Anticoagulants in UK

Phase: N/A Priority: Normal
NCT ID: NCT03119116 Org: User:
Start: 05/15/17 End: 04/16/19 Due: 04/16/20

Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT02159326 Org: User:
Start: 06/30/14 End: 07/31/15 Due: 07/31/16

Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01013909 Org: User:
Start: 12/31/09 End: 05/31/10 Due: 05/31/11

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

Phase: N/A Priority: Normal
NCT ID: NCT00824187 Org: User:
Start: 01/31/09 End: 01/31/11 Due: 01/31/12

Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging

Phase: N/A Priority: Normal
NCT ID: NCT00623467 Org: User:
Start: 12/31/07 End: 12/31/08 Due: 12/31/09

Angeliq Regulatory Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01064453 Org: User:
Start: 06/30/07 End: 12/31/12 Due: 12/31/13

A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05800444 Org: User:
Start: 04/03/23 End: 07/19/23 Due: 07/19/24

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

Phase: N/A Priority: Normal
NCT ID: NCT01104584 Org: User:
Start: 05/31/10 End: 01/31/12 Due: 01/31/13

Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse

Phase: N/A Priority: Normal
NCT ID: NCT00667979 Org: User:
Start: 09/30/04 End: 12/31/04 Due: 12/31/05

A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.

Phase: N/A Priority: Normal
NCT ID: NCT04722679 Org: User:
Start: 05/11/21 End: 01/03/22 Due: 01/03/23

A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)

Phase: N/A Priority: Normal
NCT ID: NCT03887780 Org: User:
Start: 10/03/19 End: 12/16/24 Due: 12/16/25

Effect of Riociguat on Bone Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT00855660 Org: User:
Start: 03/31/09 End: 07/31/10 Due: 07/31/11

Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine

Phase: N/A Priority: Normal
NCT ID: NCT01062360 Org: User:
Start: 12/23/05 End: 05/14/07 Due: 05/14/08

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

Phase: N/A Priority: Normal
NCT ID: NCT05915702 Org: User:
Start: 07/24/23 End: 12/17/24 Due: 12/17/25

Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis

Phase: N/A Priority: Normal
NCT ID: NCT00493038 Org: User:
Start: 02/28/06 End: 01/31/08 Due: 01/31/09

Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blocker

Phase: N/A Priority: Normal
NCT ID: NCT01945606 Org: User:
Start: 11/29/13 End: 03/17/15 Due: 03/17/16

Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01638910 Org: User:
Start: 06/30/12 End: 11/30/14 Due: 11/30/15

Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03996473 Org: User:
Start: 03/06/20 End: 01/30/23 Due: 01/30/24

Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)

Phase: N/A Priority: Normal
NCT ID: NCT04126733 Org: User:
Start: 10/14/19 End: 03/28/22 Due: 03/28/23

Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes

Phase: N/A Priority: Normal
NCT ID: NCT00206622 Org: User:
Start: 12/31/04 End: 02/28/06 Due: 02/28/07

Dose-escalation Study of Lupartumab Amadotin (BAY1129980)

Phase: N/A Priority: Normal
NCT ID: NCT02134197 Org: User:
Start: 05/22/14 End: 08/30/18 Due: 08/30/19

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years

Phase: N/A Priority: Normal
NCT ID: NCT05381142 Org: User:
Start: 05/23/22 End: 07/11/22 Due: 07/11/23